| Akers
engaged Bridgehead Consulting as consulting experts to assist
in the preparation of an expert report for inclusion in their
placing prospectus.
-
Examine and report on Akers Biosciences'
diagnostic technologies, the major products that have
been developed for production and sale using these technologies,
and the claims that Akers makes for its technology and
developed products.
-
Review and report upon the key merits
and competitive position of Akers' technologies.
-
Assess the market potential for Akers'
technologies and products.
-
Review and report upon Akers' regulatory
strategy and the regulatory framework in which it operates.
-
Review and comment upon Akers' commercial
strategy for its Particle Immnofiltration Assay (PIFA)
and Micro Particle Catalysed (MPC) Biosensor technologies
and the potential value to it of such technologies.
-
Review and report upon the Akers' research
and development programmes.
The programme of work
The programme of work was focused on developing
a legally acceptable and verifiable expert report. In this
project, Bridgehead Consulting provided verification for all
statements made in the expert report within a fully referenced
consultant's long form document, provided to Akers' and its
advisers. The document also contained transcripts of all interviews
and meetings with employees and partners of the company and
external experts and site visits. |
|
The
project achievements |
-
Understanding of the immunodiagnostic
and nucleic acid diagnostic technologies involved.
-
Understanding and familiarity with
the markets addressed by the Akers' technologies
and products.
-
Commercial appreciation of the
Akers' market approach.
Added value
For this US company floating on AIM,
Bridgehead Consulting was able to add its experience
of developing other expert reports to the requirements
of AIM. The understanding of the process and its requirements
allowed for the development of the expert report to
a high standard within the short timescales available. |
| |
|
PDF Version